Status: Not yet recruiting
Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3
Evaluation of the efficacy and safety of stiripentol in patients 6 years and older with primary hyperoxaluria type 1, 2 or 3.
Participants needed: 42
Trial details
Phase: Phase 3Age: 6+Biological sex: AllType: InterventionalSponsor: BiocodexUpdated: Jun 18, 2024
Eligibility criteria
1. Male or female patients aged ≥ 6 years at the time of consent signature [+10]
1. Any relevant change in the use of any component of the standard of care (flui... [+17]